By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Protein Sciences Corporation 

1000 Research Parkway

Meriden  Connecticut  06450  U.S.A.
Phone: 203-686-0800 Fax: 203-686-0268



Company News
Protein Sciences Corporation Release: FDA Approves Flublok Quadrivalent Influenza Vaccine 10/12/2016 6:41:03 AM
Protein Sciences Corporation And Avanzcare Announce Licensing Of Influenza Vaccines For The MENA Region 9/22/2016 10:04:25 AM
BARDA Awards Protein Sciences Corporation Multi-Million Dollar Contract For Pandemic Preparedness 9/7/2016 9:24:45 AM
Protein Sciences Corporation Release: First Doses of Flublok Influenza Vaccine of 2016/17 Have Shipped 8/10/2016 9:12:35 AM
Protein Sciences Corporation Release: 2016/17 Formulation Of Flublok Influenza Vaccine Receives FDA Approval 7/12/2016 8:18:59 AM
Protein Sciences Corporation Release: Flublok Influenza Vaccine Is A Great Alternative For FluMist For Adults 18 And Older 6/30/2016 10:05:06 AM
UMN Pharma Joins Protein Sciences Corporation' International Zika Vaccine Consortium 6/29/2016 12:04:03 PM
Protein Sciences Corporation Announces Exclusive License To uniQure (QURE) Of Cell Line And Technology For Production Of Human Gene Therapies 6/28/2016 10:07:50 AM
Protein Sciences Corporation Release: FDA Approved Longer Shelf Life For The Game Changer, Flublok Influenza Vaccine 6/23/2016 10:02:44 AM
Protein Sciences Corporation, Sinergium Biotech And Mundo Sano Announce Zika Vaccine Partnership 4/19/2016 9:47:39 AM